Trial Profile
An observational study of telbivudine in Chinese patients with chronic hepatitis B assessing cumulative incidence and risk factors of CK elevation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2017
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 06 Nov 2017 New trial record